Pharmacy Times September 12, 2024

Glenn Balasky discusses AI’s potential to change oncology care and optimize patient outcomes.

In an interview with Pharmacy Times® at the Community Oncology Alliance (COA) 2024 Payer Exchange, Glenn Balasky, executive director at Rocky Mountain Cancer Centers in Colorado, spoke about the potential for AI to influence payment reform, health care disparities, and the transition to a value-based care model.

Pharmacy Times: What were the most significant discussions in your session AI?

Glenn Balasky: The biggest discussion we had about AI at this morning’s meeting was that it’s a new subject. So, there’s a lot to happen, a lot to evolve. Dan Lodder, my colleague, who I’ve known for a number of years, has worked with technology that I think...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Equity/SDOH, Healthcare System, Interview / Q&A, Provider, Technology, Trends
How HP sees the era of the AI PC | Alex Cho
Who Wins If The New Biden AI Export Rules Stand?
AI's role in stroke care at Orlando Health, 2 years in
WindRose Invests in CIVIE, an AI-Powered Radiology Solutions Provider
Arcadia Launches AI-Powered Precision Medicine Solution

Share This Article